Received Nov 6, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (NO BRAND NAME) | UNKNOWN MANUFACTURER | UNK | UNK | — |
Vision loss from the vaccine; This serious case was reported by a consumer via interactive digital media and described the occurrence of loss of vision in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis. On an unknown date, the patient received Shingles vaccine. On an unknown date, an unknown time after receiving Shingles vaccine, the patient experienced loss of vision (Verbatim: Vision loss from the vaccine) (serious criteria GSK medically significant). The outcome of the loss of vision was not reported. The reporter considered the loss of vision to be related to Shingles vaccine. The company considered the loss of vision to be unrelated to Shingles vaccine. Additional Information: GSK Receipt Date: 03-NOV-2025 This case was reported by a patient via interactive digital media. The batch number was not provided, and unable to contact the reporter.; Sender's Comments: A case of Blindness, unknown time after receiving a dose of Shingles vaccine in a subject. Based on the available information a possible causality that the event was caused by the GSK product cannot be ascertained. Consent for further follow up has not been received.